1. Home
  2. WHLR vs ARTL Comparison

WHLR vs ARTL Comparison

Compare WHLR & ARTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Wheeler Real Estate Investment Trust Inc.

WHLR

Wheeler Real Estate Investment Trust Inc.

HOLD

Current Price

$2.41

Market Cap

4.2M

Sector

Real Estate

ML Signal

HOLD

Logo Artelo Biosciences Inc.

ARTL

Artelo Biosciences Inc.

HOLD

Current Price

$1.56

Market Cap

3.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WHLR
ARTL
Founded
2011
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.2M
3.4M
IPO Year
2012
N/A

Fundamental Metrics

Financial Performance
Metric
WHLR
ARTL
Price
$2.41
$1.56
Analyst Decision
Buy
Analyst Count
0
3
Target Price
N/A
$30.00
AVG Volume (30 Days)
5.4M
1.2M
Earning Date
11-06-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
61.36
N/A
Revenue
$101,834,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$0.04
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.36
$1.52
52 Week High
$6,719.86
$28.60

Technical Indicators

Market Signals
Indicator
WHLR
ARTL
Relative Strength Index (RSI) 45.20 31.27
Support Level $2.36 $1.75
Resistance Level $6.85 $1.93
Average True Range (ATR) 0.70 0.21
MACD -0.11 0.04
Stochastic Oscillator 1.00 5.45

Price Performance

Historical Comparison
WHLR
ARTL

About WHLR Wheeler Real Estate Investment Trust Inc.

Wheeler Real Estate Investment Trust Inc is a self-managed commercial real estate investment company. It owns, leases, and operates income-producing retail properties with a primary focus on grocery-anchored centers. The company's properties include Alex City Marketplace in Alexander City, Alabama; Bryan Station in Lexington, Kentucky; Cardinal Plaza in Henderson, North Carolina; Clover Plaza in Clover, South Carolina; Winslow Plaza in Sicklerville, New Jersey and many more.

About ARTL Artelo Biosciences Inc.

Artelo Biosciences Inc is a United States-based development-stage biopharmaceutical company. It is engaged in the development of therapeutics that target lipid signaling pathways, including the endocannabinoid system, a family of receptors & neurotransmitters that form a biochemical communication network in the body. It is focused on discovering, licensing, developing, & commercializing treatments that control endocannabinoid systems. The company pursues technologies & programs that offer proprietary approaches to cannabinoid-based therapies, & those derived from the cannabis plant & synthetic cannabinoids, as well as new chemical entities & compounds. The firm's flagship program is designed to be a patent-protected cannabinoid drug combination treatment for a rare & orphan disease.

Share on Social Networks: